成人急性低氧性呼吸衰竭的无创氧疗策略:系统评价与网状Meta分析
该系统评价与网状Meta分析纳入36项随机对照试验共7046例急性低氧性呼吸衰竭患者,比较多种无创氧疗策略。结果显示,与标准氧疗相比,头盔CPAP可能降低死亡率(每1000例减少231例死亡,95%CI 126-273,中等确定性),HFNC可能减少有创机械通气需求(每1000例减少103.5例事件,95%CI 40.5-157.5,中等确定性)。所有无创氧疗策略可能缩短住院时间(低确定性);头盔双水平通气可能缩短ICU停留时间(减少4.84天,95%CI 2.33-7.36,低确定性)。标准氧疗可能比面罩无创通气更舒适,与HFNC舒适度无差异(均低确定性)。
要点
- 与标准氧疗相比,头盔CPAP可能降低死亡率(每1000例减少231例死亡,95%CI 126-273,中等确定性)。
- 与标准氧疗相比,HFNC可能减少有创机械通气需求(每1000例减少103.5例事件,95%CI 40.5-157.5,中等确定性)。
- 与标准氧疗相比,所有无创氧疗策略可能缩短住院时间(低确定性)。
- 与标准氧疗相比,头盔双水平通气可能缩短ICU停留时间(减少4.84天,95%CI 2.33-7.36,低确定性)。
- 标准氧疗可能比面罩无创通气更舒适,与HFNC舒适度无差异(均低确定性)。
适用人群与场景
- 成人急性低氧性呼吸衰竭患者。
研究设计与关键结果
- 研究类型:系统评价与随机效应频率学网状Meta分析,纳入36项随机对照试验,共7046例患者。
- 主要终点:与标准氧疗相比,头盔CPAP可能降低死亡率(每1000例减少231例死亡,95%CI 126-273,中等确定性)。
- 与标准氧疗相比,HFNC可能减少有创机械通气需求(每1000例减少103.5例事件,95%CI 40.5-157.5,中等确定性)。
- 与标准氧疗相比,所有无创氧疗策略可能缩短住院时间(低确定性)。
- 与标准氧疗相比,头盔双水平通气可能缩短ICU停留时间(减少4.84天,95%CI 2.33-7.36,低确定性);头盔CPAP可能缩短ICU停留时间(减少1.74天,95%CI 减少4.49天至增加1.01天,低确定性)。
- 舒适度:标准氧疗可能比面罩无创通气更舒适,与HFNC舒适度无差异(均低确定性)。
证据类型、等级与局限
- 证据类型:系统评价与网状Meta分析,采用GRADE框架评级。
- 证据确定性:头盔CPAP降低死亡率为中等确定性;HFNC减少有创机械通气为中等确定性;缩短住院时间、缩短ICU停留时间及舒适度比较为低确定性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于成人急性低氧性呼吸衰竭患者,头盔CPAP可能降低死亡率,HFNC可能减少有创机械通气需求,这些信息可能影响无创氧疗策略的选择。
- 标准氧疗可能比面罩无创通气更舒适,与HFNC舒适度无差异,选择时需考虑患者耐受性。
- 作者认为,需要进一步研究以理解这些接口在急性低氧性呼吸衰竭中的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Several recently published randomized controlled trials have evaluated various noninvasive oxygenation strategies for the treatment of acute hypoxemic respiratory failure.
RESEARCH QUESTION: Which available noninvasive oxygen strategies are effective for acute hypoxic respiratory failure?
STUDY DESIGN AND METHODS: A systematic review of Medline, Embase, Cochrane CENTRAL, CINAHL, Web of Science, MedRxiv, and Research Square was conducted from inception to October 1, 2022. A random effects frequentist network meta-analysis was performed, and the results are presented using absolute risk difference per 1,000 patients. The Grading of Recommendations, Assessment, Development and Evaluation framework was used to rate the certainty of the evidence. Mortality, invasive mechanical ventilation, duration of hospitalization and ICU stay, ventilator-free days, and level of comfort are reported.
RESULTS: Thirty-six trials (7,046 patients) were included. It was found that helmet CPAP probably reduces mortality compared with standard oxygen therapy (SOT) (231 fewer deaths per 1,000; 95% CI, 126-273 fewer) (moderate certainty). A high-flow nasal cannula (HFNC) probably reduces the need for invasive mechanical ventilation (103.5 fewer events per 1,000; 95% CI, 40.5-157.5 fewer) (moderate certainty). All noninvasive oxygenation strategies may reduce the duration of hospitalization as compared with SOT (low certainty). Helmet bilevel ventilation (4.84 days fewer; 95% CI, 2.33-7.36 days fewer) and helmet CPAP (1.74 days fewer; 95% CI, 4.49 fewer-1.01 more) may reduce the duration of ICU stay as compared with SOT (both low certainty). SOT may be more comfortable than face mask noninvasive ventilation and no different in comfort compared with an HFNC (both low certainty).
INTERPRETATION: A helmet interface for noninvasive ventilation probably reduces mortality and the risk of mechanical ventilation, as well as the duration of hospital and ICU stay. An HFNC probably reduces the risk of invasive mechanical ventilation and may be as comfortable as SOT. Further research is necessary to understand the role of these interfaces in acute hypoxemic respiratory failure.
参考来源
- Pitre T, Zeraatkar D, Kachkovski GV, et al. Noninvasive Oxygenation Strategies in Adult Patients With Acute Hypoxemic Respiratory Failure: A Systematic Review and Network Meta-Analysis. Chest. 2023. PMID: 37085046. doi:10.1016/j.chest.2023.04.022
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。